A study investigating safety, efficacy and pharmacokinetics of Sofosubuvir plus Ribavirin in patients with chronic genotype 1 or 3 hepatitis C infection with severe renal impairment.
Phase of Trial: Phase I
Latest Information Update: 28 Dec 2015
At a glance
- Drugs Sofosbuvir (Primary) ; Ribavirin
- Indications Hepatitis C
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 28 Dec 2015 New trial record